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dTATE-OF-THE-ART PAPER2129Inflammation and Atherosclerosiseter Libby, Paul M. Ridker, Göran K. Hansson, for the Leducq Transatlantic Network on Atherothrombosis
ibby and colleagues describe the recent transition in the understanding of atherosclerosis
rom a bland proliferative process to an active one involving multiple components of the
ody’s immune system. Those various components are reviewed in this paper, which begins
ith an overview of the important roles that both innate and cellular immunity play. The
nteraction between inflammation and thrombosis is also discussed. This review also discusses
ow translation of these advances in understanding the pathophysiology may change clinical
ractice, either through the use of biomarkers, such as high-sensitivity C-reactive protein, or
ovel agents that target specific actors in the inflammatory cascade.VIEWPOINT IEWPOINT2139A Half Century of Selective Coronary Arteriographylbert V. G. Bruschke, William C. Sheldon, Earl K. Shirey, William L. Proudfit
he first “selective” coronary arteriogram was made 50 years ago by Dr. F. Mason Sones at
he Cleveland Clinic. Soon afterward, coronary arteriography was suitable for widespread
linical application. This has revolutionized our understanding of coronary artery disease and
as become the basis for selecting and evaluating therapeutic interventions. This paper by
ruschke and colleagues commemorates the achievements of the pioneers of coronary
rteriography, reviews the difficulties they encountered, and highlights their impact on the
evelopment of modern cardiology.(continued on page A-30)
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ENTERVENTIONAL CARDIOLOGY2145CMR Study Demonstrates Benefits of Prompt Primary PCIarco Francone, Chiara Bucciarelli-Ducci, Iacopo Carbone, Emanuele Canali, Raffaele Scardala,
rancesca A. Calabrese, Gennaro Sardella, Massimo Mancone, Carlo Catalano, Francesco Fedele,
oberto Passariello, Jan Bogaert, Luciano Agati
rancone and colleagues investigated the relationship between myocardial damage and time to
eperfusion using cardiovascular magnetic resonance (CMR) in patients with ST-segment
levation myocardial infarction who underwent primary percutaneous coronary intervention
PCI). Myocardial edema and necrosis were quantified as the area at risk and infarct size,
espectively; salvaged myocardium was defined as the difference between the two. Shorter
ime to reperfusion (90 min) was associated with smaller infarct size and larger salvaged
yocardium. Salvaged myocardium markedly decreased when reperfusion occurred 90 min
fter symptom onset. Time to reperfusion determines the extent of reversible and irreversible
yocardial injury, with 90 min from symptom onset being an important threshold.ditorial Comment: Richard W. Smalling, p. 2154NTERVENTIONAL CARDIOLOGY2157One Dose of Atorvastatin Reduces Rates of Periprocedural MIarlo Briguori, Gabriella Visconti, Amelia Focaccio, Bruno Golia, Alaide Chieffo, Alfredo Castelli,
arco Mussardo, Matteo Montorfano, Bruno Ricciardelli, Antonio Colombo
ome data suggests that statins can reduce the rates of periprocedural myocardial infarction
MI) in patients undergoing percutaneous coronary intervention (PCI). Briguori and
olleagues hypothesized that this benefit is due to their “pleiotropic” effects, independent of
holesterol reduction, and that this benefit could develop within 24 h. Statin-naive subjects
ndergoing elective PCI were randomized to either a single 80-mg dose of atorvastatin, given
ithin 24 h of the procedure, or usual care. Periprocedural MI, defined as a creatine kinase-
yocardial isoenzyme elevation 3 times the upper limit of normal, occurred in 9.5% of the
torvastatin group and 15.8% of the control group. Similar reductions were found with
roponin elevation. A single dose of atorvastatin reduces the incidence of periprocedural MI
n elective PCI.
ditorial Comment: Sotirios Tsimikas, p. 2164(continued on page A-36)
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cORONARY ARTERY DISEASE
2167utopsy Study: Microemboli and Microvascular Obstruction
After Acute Coronary Thrombosisobert S. Schwartz, Allen Burke, Andrew Farb, David Kaye, John R. Lesser, Timothy D. Henry,
enu Virmani
chwartz and colleagues studied the histopathology of epicardial coronary artery plaque in
atients dying from coronary artery occlusion and its relationship to microemboli and
icrovascular obstruction. Hearts from patients experiencing sudden coronary death
nderwent a histopathologic examination. There were 26 plaque ruptures and 21 plaque
rosions in these 44 hearts, with a mean of 4.5 microemboli per heart. Vascular microemboli
nd microvascular obstruction occurred more often from plaque showing erosion rather
han rupture, but intramyocardial microemboli were more common after plaque rupture.
icroemboli and microvascular obstruction are common in patients dying of acute
oronary thrombosis caused by plaque erosion.IOMARKERS2174Soluble ST2 Predicts Risk of SCD in Patients With Chronic Heart Failureomingo A. Pascual-Figal, Jordi Ordoñez-Llanos, Pedro L. Tornel, Rafael Va´zquez, Teresa Puig,
ariano Valdés, Juan Cinca, Antoni Bayes de Luna, MAntoni Bayes-Genis, on behalf of the
USIC Investigators
ascual-Figal and colleagues used a large registry of patients with heart failure to determine if
he soluble form of ST2 (sST2), an interleukin-1 receptor family member, predicts the risk of
udden cardiac death (SCD). A nested case-control study was performed on 36 cases of SCD
nd 63 controls (matched for age, sex, and left ventricular ejection fraction) enrolled in a
egistry of ambulatory heart failure patients. Concentrations of sST2 were higher among
hose who died. Combining sST2 and N-terminal pro–B-type natriuretic peptide (NT-
roBNP) improved the accuracy: only 4% of patients with low sST2 and low NT-proBNP
xperienced SCD. The rate was 34% when either marker was elevated and 71% when both
arkers were elevated. sST2 may be useful for predicting the risk of SCD, especially when
ombined with NT-proBNP.(continued on page A-38)
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EONGENITAL HEART DISEASE2180Percutaneous Stenting Compared to the Blalock-Taussig Shuntiuseppe Santoro, Giovanbattista Capozzi, Giuseppe Caianiello, Maria Teresa Palladino, Chiara Marrone,
abriella Farina, Maria Giovanna Russo, Raffaele Calabrò
his study sought to determine if arterial duct (AD) stenting or a modified Blalock-Taussig
hunt (MBTS) was more successful at stimulating growth in the pulmonary arteries (PAs) in
eonates with congenital heart disease with duct-dependent pulmonary circulation. Subjects
ho had undergone one of the procedures were compared. The PA growth was angio-
raphically assessed using a variety of indexes, and the right-to-left PA diameter ratio was
easured as a surrogate of uniform growth. After 10 months, both options had promoted a
ignificant increase in PA size; however, the surgical shunt caused a worsening of the left-to-
ight PA diameter ratio due to growth of the PA contra-lateral to the shunt. Percutaneous
D stenting appears to be as effective as MBTS in promoting PA growth and may result in
ore balanced pulmonary vascular development.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH2187ALDH2 Ameliorates Acute Cardiac Toxicity of Ethanoleng Ma, Ji Li, Feng Gao, Jun Ren
a and colleagues hypothesized that acetaldehyde, which is the first metabolic product of
thanol, may be the toxic factor that causes alcoholic cardiomyopathy. They tested this
ypothesis by generating a strain of transgenic mice with cardiac overexpression of
itochondrial aldehyde dehydrogenase-2 (ALDH2), which breaks down acetaldehyde. Wild-
ype and ALDH2 mice were injected with ethanol (3 g/kg, intraperitoneally), and cardiac
unction was assessed 24 h later using both Langendroff and cardiomyocyte edge-detection
ystems. The deteriorations in myocardial and cardiomyocyte contractile function were
lleviated by ALDH2. Furthermore, ethanol-induced myocardial apoptosis, protein damage,
nd mitochondrial membrane potential depolarization were lessened in ALDH2 mice. This
tudy demonstrates that ALDH2 may be protective against acute ethanol-induced cardiac
oxicity.ditorial Comment: Joel S. Karliner, p. 2197
